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ABSTRACT
Background: Although the dominant current viewpoint of insight is related to clinical insight, cognitive insight has been 
gaining popularity since the introduction of Beck Cognitive Insight Scale (BCIS) in 2004. Therefore, an easy and reliable assess-
ment tool of cognitive insight is needed to complement the assessment of clinical insight to improve the psychiatric services and 
outcomes.
Objectives: This study aimed to validate the Malay Beck Cognitive Insight Scale (BCIS-M).
Methods: The BCIS was translated into Malay language with good face and content validity. It was administered to 75 
patients with schizophrenia in psychiatric outpatient clinic, Hospital Universiti Sains Malaysia (HUSM) in April 2014. 
Results: The BCIS-M showed good psychometric property. The internal consistency (Cronbach alpha) for self-certainty and 
self-reflectiveness in this study were 0.609 and 0.699, respectively.
Conclusion: The BCIS-M is a valid and reliable tool for assessment of cognitive insight in local Malaysian population.
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INTRODUCTION
Schizophrenia, a stigmatized illness in some parts of the world 
especially in developing countries, is a chronic psychiatric disorder 
which usually affects about 1% of the population. It is severe enough to 
impact on functional areas like independent living, marriage, social and 
also occupational functioning1). The disease itself has been argued to be 
a spectrum of symptoms displayed against what the normal population 
considers as inappropriate or abnormal. These symptoms include aberra-
tions in thoughts, perceptions, emotion, behaviour and also cognitive 
functions. When cognitive functions like memory, attention and judg-
ment are impaired; improvement in illness is impeded and relapses 
become more frequently common.
As our current trend is moving towards deinstitutionalization while 
strengthening our delivery of community psychiatry service, frequent 
relapses and hospitalizations are not helping our aim to achieve a stable 
group of psychiatric patients to be treated in society. Some patients have 
been treated to the extent that they are aware of their illness but yet a 
relapse could still occur despite being deemed to have good insight. 
Having an insight is commonly defined as possessing the ability to rec-
ognize that a mental disorder is present, understand that delusions and 
hallucinations are signs of mental illness and realize the need for treat-
ment2). The term "clinical insight" usually denotes this. Although the 
blame for relapse is often put on poor medication adherence due to lack 
of insight and a fair share of observations accounted for this relation-
ship, theories have also been growing that there are possibly other 
aspects of insight that clinicians might be unaware of and left untackled. 
This then leads to the endless cycle of relapses in schizophrenia despite 
some patients clinically labelled as having good insight.
In 2004, Beck et al. popularized the idea of cognitive insight with 
the introduction of Beck Cognitive Insight Scale3). This is conceptually 
different from clinical insight but is said to be occurring in a similar 
spectrum of insight. Garety et al had found that patients with schizo-
phrenia who agreed that they could be wrong in their beliefs, showed 
better improvement in treatment outcome when psychological approach 
such as cognitive behavioural therapy (CBT) was given, as opposed to 
the other group of patients who were unshakable in their beliefs and 
received the same psychological approach4). This finding was later real-
ized to be linked to "cognitive insight", a term gaining ground only as 
recent as 2004. Since then BCIS has been translated and validated in 
several languages including Norwegian5), French6) and Tamil7). This 
study, aimed to translate and validate the scale in local population. This 
would allow more studies to be conducted in this exciting area of 
research.
METHODS
Participants
The study protocol was approved by the Human Research Ethics 
Committee (USM/JEPeM/282.3(8) and Medical Research Ethics 
Committee (NMMR-13-1184-18386). Eligible subjects gave their writ-
ten informed consent after the nature of the study was explained. Data 
were collected from 75 patients aged 18-65 with DSM-IV-TR diagnosis 
of schizophrenia attending the outpatient psychiatric clinic, Hospital 
Universiti Sains Malaysia in April 2014. All the participants were stable 
(no admission in the past 6 months), cooperative, literate and able to 
understand the Malay language.
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Instrument
a) Beck Cognitive Insight Scale (BCIS) - Malay version
The original version of BCIS was introduced by Beck et al in 2004 
to assess cognitive insight. This is a self-rated scale to evaluate patients' 
self-reflectiveness and extent of their overconfidence or self-certainty in 
their experiences and thoughts measured on a Likert scale. Each item is 
rated as "do not agree", "agree slightly", "agree a lot" and "agree com-
pletely" with each of these ratings given a score of 0, 1, 2 and 3 respec-
tively. In total, there are 15 items to be assessed.
Out of 15, nine items assess self-reflectiveness (items 1, 3, 4, 5, 6, 
8, 12, 14 and 15) while another six are under self-certainty sub-domain 
(items 2, 7, 9, 10, 11 and 13). The self-reflectiveness domain assesses 
openness to feedback, criticism and willingness to consider alternative 
explanations to unusual experiences. A maximum possible score of 27 is 
allowed. The self-certainty items assess the extent of being overconfi-
dent with one's belief, where higher scores mean a lesser chance for 
delusion to be modified. This domain has a maximum possible score of 
18. High self-reflectiveness and low self-certainty are considered nor-
mal3,8-10). 
To balance these two domains, a composite index is calculated to 
represent overall cognitive insight. This is obtained by subtracting 
self-certainty scores from self-reflectiveness scores. A low composite 
score reflects poor cognitive insight. As of date, there is no common 
acceptable cut-off point to determine normal or abnormal scores of cog-
nitive insight. There is also no other comparable tool that measures cog-
nitive insight.
The researcher managed to obtain the consent to translate the scale 
from the original author. Forward and back translation process of the 
BCIS was independently carried out by 2 sets of bilingual translators 
comprised of a psychiatrist and linguist. The forward and back translat-
ed versions were reviewed and amended to improve the semantic accu-
racy while maintaining the intended original meaning of the English 
version. This amended scale was then agreed upon in consensus by the 
expert team to have good content validity. The scale was then pre-tested 
on a group of ten patients with schizophrenia to assess its face validity. 
All patients agreed that the questions appeared to be measuring what it 
was supposed to measure. Hence, the finalized Malay version of Beck 
Cognitive Insight Scale (BCIS-M) was deemed to have satisfactory 
semantic and conceptual equivalence with the original version as well as 
good face and content validity
RESULTS
Psychometric properties
Cronbach alpha for self-certainty and self-reflectiveness in this 
study were 0.609 and 0.699, respectively (table 1). Although, there are 
differing opinions regarding the appropriate level of Cronbach alpha, no 
fixed value has been agreed upon, although conventionally the accept-
able range is usually from 0.6 to 0.7 and above11). Above 0.7 was consid-
ered good and commonly quoted in research based on an earlier recom-
mendation by Nunally12). Overall, the reliability of the Malay version 
was comparable to the original English version where the value stood at 
0.61 for self-certainty and 0.67 for self-reflectiveness in patients with 
schizophrenia3). Other translated works also produced values of similar 
ranges (table 2).
In this reliability analysis, when deletion of items occurred, the 
majority of Cronbach alpha showed a reduction in alpha values as 
opposed to only three items showing a small, negligible increment in 
alpha values. Hence, to maintain conceptual accuracy, all items were 
retained for use in the translated questionnaire. Overall, this preliminary 
work thus showed that the BCIS-M is reliable and acceptable as a 
research tool.
DISCUSSION
Cognitive insight measures the ability of patient's higher mental 
functioning to assess and re-evaluate their distorted thoughts and 
beliefs, their openness to criticism, and how firmly they believe in their 
delusions3). Thus, patients with a high level of psychosis are expected to 
have lower cognitive insight but this relationship has been inconclusive 
somewhat. Other factors could have played a role in determining good 
cognitive insight and as to our understanding, the evaluation and correc-
tion of these pathological symptoms require good cognition to perform 
the reappraisal and avoid misinterpretation.
A good clinical insight may also not necessarily be translated into 
good cognitive insight. Some patients may agree that they are mentally 
ill and the unusual experiences are due to mental disorder but without 
themselves being convinced of this3). Assessment on cognitive insight 
can thus complement clinical insight to make the usual insight evalua-
tion more comprehensive and representative of an individual's mental 
state. This is a good step to bring the patient to a more serious level of 
recovery by ensuring successful adherence to treatment and continuous 
engagement in a therapeutic doctor-patient partnership. Negative emo-
tions like frustrations, helplessness and anger from the frequent relapses 
could also be minimized.
Availability of validated scale to measure cognitive insight would 
complement the assessment of clinical insight. More knowledge about 
cognitive insight can be gained by using appropriate investigative tools. 
Specific cognitive remediation therapies could later be formulated, sug-
gested or devised to enhance neurocognitive abilities in order to 
improve cognitive insight. Better cognitive insight inevitably helps ele-
vate patient's potential functional outcome by achieving greater adher-
ence to medication, therapies and simultaneously reducing relapses that 
have been linked to treatment non-compliance. Further, poor or negative 
caregiving experiences could lead to lower perceived social support by 
patients13). On the other hand, good or positive caregiving experiences 
potentially improve the prognosis of patients with schizophrenia.
Table 1. Internal consistency of self-certainty and self-reflec-
tiveness domain of Malay BCIS
Item Corrected Item-Total  Cronbach's Alpha if Item 
 Correlation Deleted
Self-certainty
Q2 0.318 0.575
Q7 0.489 0.500
Q9 0.247 0.602
Q10 0.396 0.544
Q11 0.387 0.546
Q13 0.225 0.612
Self-reflectiveness  
Q1 0.451 0.658
Q3 0.384 0.671
Q4 0.257 0.696
Q5 0.465 0.654
Q6 0.651 0.613
Q8 0.581 0.632
Q12 0.143 0.710
Q14 0.110 0.726
Q15 0.351 0.677
Cronbach alpha for self-certainty = 0.609 and self-reflectiveness = 0.699
Table 2. Comparison of BCIS internal consistencies in different 
languages 
Language Self-certainty Self-reflectiveness
Malay 0.609 0.699
English (Beck et al., 2004) 0.610 0.670
Norwegian (Jónsdóttir et al., 2008) 0.630 0.720
French (Favrod et al., 2008) 0.620 0.730
Tamil (Merlin et al., 2012) 0.610 0.650
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CONCLUSION
The Malay version of the Beck Cognitive Insight Scale (BCIS) has 
good internal reliability and suitable for local use. This instrument 
would enable researchers to further investigate cognitive insight in 
schizophrenia and its associated factors in future study.
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